IJR iShares Core S&P Small Cap ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| EMN | 0.55% |
| VIAV | 0.54% |
| AGX | 0.53% |
| PRIM | 0.53% |
| FORM | 0.52% |
| ESI | 0.52% |
| LKQ | 0.51% |
| SM | 0.50% |
| SANM | 0.49% |
| ESE | 0.49% |
ETF Analysis
Fund Overview
iShares Core S&P Small Cap ETF (IJR) currently reports 599 stock positions (subject to change), placing it in the expansively diversified range by holdings breadth. The top line-up is EMN (0.55%), VIAV (0.54%), AGX (0.53%), with EMN as the largest single weight at 0.55%. Together, the top three holdings account for 1.62%, which indicates that idiosyncratic risk at the top of the book is relatively contained within the overall portfolio. The resulting profile combines thematic conviction with varying degrees of diversification, which can support upside participation while still spreading idiosyncratic risk beyond the top weights.
Profitability & Capital Efficiency
From a returns-on-capital standpoint, ROIC is 9.68%, WACC is 8.25%, and the economic spread is 1.43%. On balance, the portfolio clears its capital cost hurdle modestly — value creation is present but not emphatic. Supporting metrics show ROE at 10.91% and ROA at 4.85%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.
Valuation
The portfolio's current market valuation reflects trailing P/E of 16.67, forward P/E of 13.16, PEG of 3.41. The trailing-to-forward compression is minimal, consistent with a market that sees limited earnings acceleration from current levels. Growth-adjusted valuation is stretched here — the multiple implies either above-consensus growth or a willingness to pay a premium for quality. The aggregate current ratio of 2.99 points to strong liquidity across holdings. Across multiples and liquidity, the portfolio is priced in a way that reflects current expectations reasonably well — leaving limited room for error, but also limited near-term downside from valuation compression alone.
Margins & Cash Generation
On profitability at each income statement layer, gross margin sits at 44.23%, operating margin at 14.04%, and free cash flow margin at 16.79%. The portfolio's gross margins are solid, reflecting a reasonable balance between revenue realization and direct cost absorption. The operating margin reading is modest, consistent with businesses still working to scale their cost structures efficiently. Free cash flow margins are strong, reflecting capital-efficient businesses that largely self-fund their growth. Taken together, the margin stack suggests quality that is uneven — some layers are more resilient than others, and that asymmetry matters under stress.
Growth & Forward Outlook
Looking at growth and market-implied direction, TTM revenue growth of 17.31% indicating top-line growth that is constructive without being speculative. At the same time, the estimated 12-month price change of 18.94%, where implied upside appears constructive but not aggressive. It's worth distinguishing between what businesses are actually delivering and what the market is being asked to believe about the next 12 months. Maintaining alignment between reported results and forward estimates is particularly important in periods where macro uncertainty is elevated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
BuyPutting the pieces together, this is a profile with genuine merit: the numbers support confidence in the forward case without requiring heroic assumptions.
This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.